XML 65 R36.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Dispositions (Details) (USD $)
In Millions, except Per Share data
0 Months Ended 1 Months Ended 3 Months Ended 6 Months Ended
Apr. 04, 2011
May 31, 2011
Jul. 03, 2010
Jul. 02, 2011
Jul. 03, 2010
Dec. 31, 2010
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Gain (Loss) on Divestiture of Businesses   $ 3.0        
Proceeds from sale of business, net of cash divested       13.8 0  
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax 304          
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax, Per Diluted Share $ 0.78          
Revenues     55.2 54.3 105.1  
Pre-tax Income     14.0 9.1 22.5  
Other Current Assets           64.8
Other Assets           451.0
Other Accrued Expenses           17.6
Other Long-term Liabilities           58.4
Lancaster Laboratories [Member]
           
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Proceeds from sale of business, net of cash divested 180.0          
Escrowed proceeds from sale of business 20.0          
Athena Diagnostics [Member]
           
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Proceeds from sale of business, net of cash divested $ 740.0